Published in J Physiol on September 25, 2008
Genetic association of FOXO1A and FOXO3A with longevity trait in Han Chinese populations. Hum Mol Genet (2009) 2.34
Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models. Antioxid Redox Signal (2010) 1.59
Reduction of low grade inflammation restores blunting of postprandial muscle anabolism and limits sarcopenia in old rats. J Physiol (2009) 1.54
Molecular and cellular mechanisms of skeletal muscle atrophy: an update. J Cachexia Sarcopenia Muscle (2012) 1.40
Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy. FASEB J (2011) 1.39
Novel events in the molecular regulation of muscle mass in critically ill patients. J Physiol (2011) 1.28
mTor signaling in skeletal muscle during sepsis and inflammation: where does it all go wrong? Physiology (Bethesda) (2011) 1.16
Sepsis increases the expression and activity of the transcription factor Forkhead Box O 1 (FOXO1) in skeletal muscle by a glucocorticoid-dependent mechanism. Int J Biochem Cell Biol (2010) 1.10
p300 Acetyltransferase activity differentially regulates the localization and activity of the FOXO homologues in skeletal muscle. Am J Physiol Cell Physiol (2011) 1.07
Isotretinoin and FoxO1: A scientific hypothesis. Dermatoendocrinol (2011) 1.02
Structure to function: muscle failure in critically ill patients. J Physiol (2010) 0.99
Regulation of muscle pyruvate dehydrogenase complex in insulin resistance: effects of exercise and dichloroacetate. Diabetes Metab J (2013) 0.99
Mitochondrial dysfunction and biogenesis: do ICU patients die from mitochondrial failure? Ann Intensive Care (2011) 0.98
Low-dose dexamethasone prevents endotoxaemia-induced muscle protein loss and impairment of carbohydrate oxidation in rat skeletal muscle. J Physiol (2010) 0.97
Role of Inflammation in Muscle Homeostasis and Myogenesis. Mediators Inflamm (2015) 0.93
Pharmacological activation of the pyruvate dehydrogenase complex reduces statin-mediated upregulation of FOXO gene targets and protects against statin myopathy in rodents. J Physiol (2012) 0.91
Activated protein synthesis and suppressed protein breakdown signaling in skeletal muscle of critically ill patients. PLoS One (2011) 0.85
Inhibition of glycogen synthase kinase 3[beta] activity with lithium in vitro attenuates sepsis-induced changes in muscle protein turnover. Shock (2011) 0.84
FOXO1 Mediates Vitamin D Deficiency-Induced Insulin Resistance in Skeletal Muscle. J Bone Miner Res (2015) 0.82
Role of protein farnesylation in burn-induced metabolic derangements and insulin resistance in mouse skeletal muscle. PLoS One (2015) 0.80
Identification of four novel serum protein biomarkers in sepsis patients encoded by target genes of sepsis-related miRNAs. Clin Sci (Lond) (2014) 0.79
Control of skeletal muscle atrophy in response to disuse: clinical/preclinical contentions and fallacies of evidence. Am J Physiol Endocrinol Metab (2016) 0.79
Dexmedetomidine May Produce Extra Protective Effects on Sepsis-induced Diaphragm Injury. Chin Med J (Engl) (2015) 0.78
Effects of endotoxaemia on protein metabolism in rat fast-twitch skeletal muscle and myocardium. PLoS One (2009) 0.78
Remifentanil and glucose suppress inflammation in a rat model of surgical stress. Surg Today (2011) 0.78
Poor maternal nutrition inhibits muscle development in ovine offspring. J Anim Sci Biotechnol (2014) 0.77
αMSH blunts endotoxin-induced MuRF1 and atrogin-1 upregulation in skeletal muscle by modulating NF-κB and Akt/FoxO1 pathway. Mediators Inflamm (2014) 0.77
The quasi-parallel lives of satellite cells and atrophying muscle. Front Aging Neurosci (2015) 0.77
Variability of protein level and phosphorylation status caused by biopsy protocol design in human skeletal muscle analyses. BMC Res Notes (2011) 0.76
Exercise-induced AMPK and pyruvate dehydrogenase regulation is maintained during short-term low-grade inflammation. Pflugers Arch (2014) 0.75
Out-FOX(O)ing proteolysis in sepsis. J Physiol (2010) 0.75
D-TRP(8)-γMSH Prevents the Effects of Endotoxin in Rat Skeletal Muscle Cells through TNFα/NF-KB Signalling Pathway. PLoS One (2016) 0.75
Case report: severe reversible cardiomyopathy associated with systemic inflammatory response syndrome in the setting of diabetic hyperosmolar hyperglycemic non-ketotic syndrome. BMC Cardiovasc Disord (2015) 0.75
FOXO, the spindle in the net for wasting diseases? J Physiol (2008) 0.75
Alpha-ketoglutarate promotes skeletal muscle hypertrophy and protein synthesis through Akt/mTOR signaling pathways. Sci Rep (2016) 0.75
Metabolic alterations by indoxyl sulfate in skeletal muscle induce uremic sarcopenia in chronic kidney disease. Sci Rep (2016) 0.75
miR-628 Promotes Burn-Induced Skeletal Muscle Atrophy via Targeting IRS1. Int J Biol Sci (2016) 0.75
Pre-Operative nutrition In Neck of femur Trial (POINT)--carbohydrate loading in patients with fragility hip fracture: study protocol for a randomised controlled trial. Trials (2014) 0.75
Insulin modulates energy and substrate sensing and protein catabolism induced by chronic peritonitis in skeletal muscle of neonatal pigs. Pediatr Res (2016) 0.75
Glutamate alleviates muscle protein loss by modulating TLR4, NODs, Akt/FOXO and mTOR signaling pathways in LPS-challenged piglets. PLoS One (2017) 0.75
Targeting Inflammation and Downstream Protein Metabolism in Sarcopenia: A Brief Up-Dated Description of Concurrent Exercise and Leucine-Based Multimodal Intervention. Front Physiol (2017) 0.75
Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med (2001) 46.58
Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature (2002) 14.37
Identification of ubiquitin ligases required for skeletal muscle atrophy. Science (2001) 12.98
The immunopathogenesis of sepsis. Nature (2002) 11.83
Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell (2004) 11.33
IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science (1996) 8.57
The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell (2004) 7.60
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J (2004) 7.02
Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev (2006) 6.68
IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell (2004) 6.25
Glycogen, glycolytic intermediates and high-energy phosphates determined in biopsy samples of musculus quadriceps femoris of man at rest. Methods and variance of values. Scand J Clin Lab Invest (1974) 4.79
Skeletal muscle hypertrophy and atrophy signaling pathways. Int J Biochem Cell Biol (2005) 3.93
Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex. Biochem J (1998) 3.36
The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. Cell Metab (2007) 2.84
Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology (2006) 2.62
Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis. J Biol Chem (1998) 2.51
Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes (2005) 2.35
Forkhead transcription factor FOXO1 (FKHR)-dependent induction of PDK4 gene expression in skeletal muscle during energy deprivation. Biochem J (2003) 2.17
Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med (2004) 2.00
Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles. J Clin Invest (1997) 1.90
Regulation of muscle protein synthesis during sepsis and inflammation. Am J Physiol Endocrinol Metab (2007) 1.75
Degradation of MyoD mediated by the SCF (MAFbx) ubiquitin ligase. J Biol Chem (2004) 1.75
Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids. J Clin Invest (1996) 1.67
Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation. Ann Surg (2001) 1.66
The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy. EMBO J (2008) 1.59
Protein kinase B-alpha inhibits human pyruvate dehydrogenase kinase-4 gene induction by dexamethasone through inactivation of FOXO transcription factors. Diabetes (2004) 1.58
Isoenzymes of pyruvate dehydrogenase phosphatase. DNA-derived amino acid sequences, expression, and regulation. J Biol Chem (1998) 1.57
Pyruvate dehydrogenase kinase-4 deficiency lowers blood glucose and improves glucose tolerance in diet-induced obese mice. Am J Physiol Endocrinol Metab (2008) 1.42
Muscle composition in relation to age and sex. Clin Sci (Lond) (1991) 1.34
A sensitive radioisotopic assay of pyruvate dehydrogenase complex in human muscle tissue. Anal Biochem (1991) 1.32
Insulin regulation of skeletal muscle PDK4 mRNA expression is impaired in acute insulin-resistant states. Diabetes (2006) 1.32
Increased mRNA levels for components of the lysosomal, Ca2+-activated, and ATP-ubiquitin-dependent proteolytic pathways in skeletal muscle from head trauma patients. Proc Natl Acad Sci U S A (1996) 1.31
Derangements in mitochondrial metabolism in intercostal and leg muscle of critically ill patients with sepsis-induced multiple organ failure. Am J Physiol Endocrinol Metab (2006) 1.31
Induction of MafBx and Murf ubiquitin ligase mRNAs in rat skeletal muscle after LPS injection. FEBS Lett (2003) 1.28
PPARdelta agonism induces a change in fuel metabolism and activation of an atrophy programme, but does not impair mitochondrial function in rat skeletal muscle. J Physiol (2007) 1.23
Intracellular regulation of protein degradation during sepsis is different in fast- and slow-twitch muscle. Am J Physiol (1997) 1.23
Tumor necrosis factor-{alpha} decreases Akt protein levels in 3T3-L1 adipocytes via the caspase-dependent ubiquitination of Akt. Endocrinology (2005) 1.22
Balancing muscle hypertrophy and atrophy. Nat Med (2004) 1.22
A descriptive study of skeletal muscle metabolism in critically ill patients: free amino acids, energy-rich phosphates, protein, nucleic acids, fat, water, and electrolytes. Crit Care Med (1996) 1.17
Proteasome proteolytic activity in skeletal muscle is increased in patients with sepsis. Clin Sci (Lond) (2007) 1.14
Sepsis-induced alterations in pyruvate dehydrogenase complex activity in rat skeletal muscle: effects on plasma lactate. Shock (1996) 1.14
Inactivity and inflammation in the critically ill patient. Crit Care Clin (2007) 1.14
Extraction of nuclear proteins from striated muscle tissue. Biotechniques (1999) 1.11
Calpain activation causes a proteasome-dependent increase in protein degradation and inhibits the Akt signalling pathway in rat diaphragm muscle. Exp Physiol (2007) 1.09
Effect of insulin on amino acid uptake and protein turnover in skeletal muscle from septic rats. Evidence for insulin resistance of protein breakdown. Arch Surg (1987) 0.99
Muscle fibre atrophy in critically ill patients is associated with the loss of myosin filaments and the presence of lysosomal enzymes and ubiquitin. Neuropathol Appl Neurobiol (1998) 0.98
Insulin sensitivity of glucose and fat metabolism in severe sepsis. Clin Sci (Lond) (2000) 0.97
Sepsis alters pyruvate dehydrogenase kinase activity in skeletal muscle. Mol Cell Biochem (1999) 0.96
Insulin-mediated glucose uptake by individual tissues during sepsis. Metabolism (1990) 0.93
Lack of effect of TNF antibodies on the cardiovascular sequelae of lipopolysaccharide infusion in conscious rats. Br J Pharmacol (1995) 0.92
Temporal changes in the involvement of pyruvate dehydrogenase complex in muscle lactate accumulation during lipopolysaccharide infusion in rats. J Physiol (2008) 0.90
Contribution of the ubiquitin-proteasome pathway to overall muscle proteolysis in hypercatabolic patients. Metabolism (2000) 0.83
Using molecular classification to predict gains in maximal aerobic capacity following endurance exercise training in humans. J Appl Physiol (1985) (2010) 2.74
Human muscle gene expression responses to endurance training provide a novel perspective on Duchenne muscular dystrophy. FASEB J (2005) 1.85
Disuse atrophy and exercise rehabilitation in humans profoundly affects the expression of genes associated with the regulation of skeletal muscle mass. FASEB J (2004) 1.75
New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle. J Physiol (2007) 1.67
Regulation of human metabolism by hypoxia-inducible factor. Proc Natl Acad Sci U S A (2010) 1.56
Randomized controlled trial of dietary creatine as an adjunct therapy to physical training in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 1.46
Systematic analysis of adaptations in aerobic capacity and submaximal energy metabolism provides a unique insight into determinants of human aerobic performance. J Appl Physiol (1985) (2009) 1.31
Novel events in the molecular regulation of muscle mass in critically ill patients. J Physiol (2011) 1.28
Insulin stimulates L-carnitine accumulation in human skeletal muscle. FASEB J (2005) 1.25
Chronic oral ingestion of L-carnitine and carbohydrate increases muscle carnitine content and alters muscle fuel metabolism during exercise in humans. J Physiol (2011) 1.24
PPARdelta agonism induces a change in fuel metabolism and activation of an atrophy programme, but does not impair mitochondrial function in rat skeletal muscle. J Physiol (2007) 1.23
Modulation of extracellular matrix genes reflects the magnitude of physiological adaptation to aerobic exercise training in humans. BMC Biol (2005) 1.21
Progesterone suppresses the inflammatory response and nitric oxide synthase-2 expression following cerebral ischemia. Exp Neurol (2005) 1.19
Mechanisms regulating muscle mass during disuse atrophy and rehabilitation in humans. J Appl Physiol (1985) (2010) 1.16
Elevated free fatty acids attenuate the insulin-induced suppression of PDK4 gene expression in human skeletal muscle: potential role of intramuscular long-chain acyl-coenzyme A. J Clin Endocrinol Metab (2007) 1.08
Oxygen uptake on-kinetics in dog gastrocnemius in situ following activation of pyruvate dehydrogenase by dichloroacetate. J Physiol (2002) 1.06
Resistance to aerobic exercise training causes metabolic dysfunction and reveals novel exercise-regulated signaling networks. Diabetes (2013) 1.02
Blunted Akt/FOXO signalling and activation of genes controlling atrophy and fuel use in statin myopathy. J Physiol (2008) 1.01
The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity. Nat Cell Biol (2012) 0.99
Low-dose dexamethasone prevents endotoxaemia-induced muscle protein loss and impairment of carbohydrate oxidation in rat skeletal muscle. J Physiol (2010) 0.97
Comparative regional haemodynamic effects of the nitric oxide synthase inhibitors, S-methyl-L-thiocitrulline and L-NAME, in conscious rats. Br J Pharmacol (2003) 0.97
Chronic treatment with the beta(2)-adrenoceptor agonist prodrug BRL-47672 impairs rat skeletal muscle function by inducing a comprehensive shift to a faster muscle phenotype. J Pharmacol Exp Ther (2006) 0.96
Increased uncoupling protein 3 content does not affect mitochondrial function in human skeletal muscle in vivo. J Clin Invest (2003) 0.95
An acute increase in skeletal muscle carnitine content alters fuel metabolism in resting human skeletal muscle. J Clin Endocrinol Metab (2006) 0.95
A validation of the application of D(2)O stable isotope tracer techniques for monitoring day-to-day changes in muscle protein subfraction synthesis in humans. Am J Physiol Endocrinol Metab (2013) 0.94
Applications of multi-nuclear magnetic resonance spectroscopy at 7T. World J Radiol (2011) 0.93
Glycogen phosphorylase inhibition in type 2 diabetes therapy: a systematic evaluation of metabolic and functional effects in rat skeletal muscle. Diabetes (2005) 0.92
The effects of fasting and refeeding with a 'metabolic preconditioning' drink on substrate reserves and mononuclear cell mitochondrial function. Clin Nutr (2010) 0.92
Inhibition of adipose tissue lipolysis increases intramuscular lipid and glycogen use in vivo in humans. Am J Physiol Endocrinol Metab (2005) 0.91
Pharmacological activation of the pyruvate dehydrogenase complex reduces statin-mediated upregulation of FOXO gene targets and protects against statin myopathy in rodents. J Physiol (2012) 0.91
Characterization of the endokinins: human tachykinins with cardiovascular activity. Proc Natl Acad Sci U S A (2003) 0.91
Tricarboxylic acid cycle intermediate pool size: functional importance for oxidative metabolism in exercising human skeletal muscle. Sports Med (2007) 0.90
Low intensity exercise in humans accelerates mitochondrial ATP production and pulmonary oxygen kinetics during subsequent more intense exercise. J Physiol (2002) 0.90
The experimental type 2 diabetes therapy glycogen phosphorylase inhibition can impair aerobic muscle function during prolonged contraction. Diabetes (2006) 0.90
Physiological control of muscle mass in humans during resistance exercise, disuse and rehabilitation. Curr Opin Clin Nutr Metab Care (2010) 0.88
Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats. Br J Pharmacol (2009) 0.88
Skeletal muscle carnitine loading increases energy expenditure, modulates fuel metabolism gene networks and prevents body fat accumulation in humans. J Physiol (2013) 0.87
Carbohydrate ingestion augments L-carnitine retention in humans. J Appl Physiol (1985) (2006) 0.87
Acetyl group availability influences phosphocreatine degradation even during intense muscle contraction. J Physiol (2004) 0.87
The in vitro and in vivo cardiovascular effects of Delta9-tetrahydrocannabinol in rats made hypertensive by chronic inhibition of nitric-oxide synthase. J Pharmacol Exp Ther (2007) 0.87
The acetyl group deficit at the onset of contraction in ischaemic canine skeletal muscle. J Physiol (2002) 0.87
Acute cardiovascular effects of sibutramine in conscious rats. J Pharmacol Exp Ther (2003) 0.86
Short-term starvation and mitochondrial dysfunction - a possible mechanism leading to postoperative insulin resistance. Clin Nutr (2009) 0.86
Excess maternal salt intake produces sex-specific hypertension in offspring: putative roles for kidney and gastrointestinal sodium handling. PLoS One (2013) 0.85
Acetyl-CoA provision and the acetyl group deficit at the onset of contraction in ischemic canine skeletal muscle. Am J Physiol Endocrinol Metab (2004) 0.85
PPARdelta agonism inhibits skeletal muscle PDC activity, mitochondrial ATP production and force generation during prolonged contraction. J Physiol (2008) 0.85
Muscle atrophy in immobilization and senescence in humans. Curr Opin Neurol (2009) 0.84
Exercise with low muscle glycogen augments TCA cycle anaplerosis but impairs oxidative energy provision in humans. J Physiol (2002) 0.84
Muscle pyruvate availability can limit the flux, but not activation, of the pyruvate dehydrogenase complex during submaximal exercise in humans. J Physiol (2004) 0.84
Reply to 'Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities'. Nat Med (2007) 0.84
Predicting in vivo cardiovascular properties of β-blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responses. FASEB J (2011) 0.84
Dichloroacetate enhances performance and reduces blood lactate during maximal cycle exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 0.83
Gender and age differences in plasma carnitine, muscle strength, and exercise tolerance in haemodialysis patients. Nephrol Dial Transplant (2002) 0.83
The neuroprotective effect of progesterone after traumatic brain injury in male mice is independent of both the inflammatory response and growth factor expression. Eur J Neurosci (2005) 0.83
Maternal fructose and/or salt intake and reproductive outcome in the rat: effects on growth, fertility, sex ratio, and birth order. Biol Reprod (2013) 0.82
Creatine supplementation does not affect human skeletal muscle glycogen content in the absence of prior exercise. J Appl Physiol (1985) (2007) 0.82
A threshold exists for the stimulatory effect of insulin on plasma L-carnitine clearance in humans. Am J Physiol Endocrinol Metab (2006) 0.82
Post-exercise ingestion of a unique, high molecular weight glucose polymer solution improves performance during a subsequent bout of cycling exercise. J Sports Sci (2008) 0.81
Implications for oxidative stress and astrocytes following 26S proteasomal depletion in mouse forebrain neurones. Biochim Biophys Acta (2013) 0.81
Vegetarians have a reduced skeletal muscle carnitine transport capacity. Am J Clin Nutr (2011) 0.81
L-arginine ingestion after rest and exercise: effects on glucose disposal. Med Sci Sports Exerc (2003) 0.80
Effects of in vivo lipopolysaccharide infusion on vasoconstrictor function of rat isolated mesentery, kidney, and aorta. J Pharmacol Exp Ther (2003) 0.80
G protein-coupled receptor kinases 2 and 5 are differentially expressed in rat skeletal muscle and remain unchanged following beta2-agonist administration. Exp Physiol (2003) 0.79
An acute decrease in TCA cycle intermediates does not affect aerobic energy delivery in contracting rat skeletal muscle. J Physiol (2005) 0.79
The temporal relationship between glycogen phosphorylase and activation of the pyruvate dehydrogenase complex during adrenaline infusion in resting canine skeletal muscle. J Physiol (2002) 0.78
Fostering orphan receptors: an indispensable role for integrative, in vivo, haemodynamic studies. Curr Opin Pharmacol (2003) 0.78
Synthesis and in vitro and in vivo characterization of highly β1-selective β-adrenoceptor partial agonists. J Med Chem (2013) 0.78
Effects of endotoxaemia on protein metabolism in rat fast-twitch skeletal muscle and myocardium. PLoS One (2009) 0.78